IDERA PHARMACEUTICALS INC's ticker is and the CUSIP is 45168K906. A total of 4 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $67,000 | +346.7% | 50,500 | +531.2% | 0.00% | – |
| Q1 2018 | $15,000 | -80.3% | 8,000 | -77.8% | 0.00% | -100.0% |
| Q4 2017 | $76,000 | -11.6% | 36,000 | -6.2% | 0.00% | 0.0% |
| Q3 2017 | $86,000 | -22.5% | 38,400 | -40.6% | 0.00% | 0.0% |
| Q2 2017 | $111,000 | -35.8% | 64,700 | -7.6% | 0.00% | -50.0% |
| Q1 2017 | $173,000 | +166.2% | 70,000 | +61.3% | 0.00% | +100.0% |
| Q4 2016 | $65,000 | -42.0% | 43,400 | -0.9% | 0.00% | 0.0% |
| Q3 2016 | $112,000 | +62.3% | 43,800 | -3.1% | 0.00% | 0.0% |
| Q2 2016 | $69,000 | -55.8% | 45,200 | -42.5% | 0.00% | -50.0% |
| Q1 2016 | $156,000 | -48.0% | 78,600 | -19.1% | 0.00% | -50.0% |
| Q4 2015 | $300,000 | -65.9% | 97,200 | -62.9% | 0.00% | -66.7% |
| Q3 2015 | $879,000 | -53.1% | 262,300 | -48.1% | 0.01% | -53.8% |
| Q2 2015 | $1,876,000 | +486.2% | 505,700 | +486.0% | 0.03% | +420.0% |
| Q1 2015 | $320,000 | -58.7% | 86,300 | -50.9% | 0.01% | -58.3% |
| Q4 2014 | $775,000 | +297.4% | 175,700 | +106.0% | 0.01% | +300.0% |
| Q3 2014 | $195,000 | +51.2% | 85,300 | +91.7% | 0.00% | +50.0% |
| Q2 2014 | $129,000 | -36.1% | 44,500 | -10.3% | 0.00% | -33.3% |
| Q1 2014 | $202,000 | – | 49,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|